1. Home
  2. EJH vs KZIA Comparison

EJH vs KZIA Comparison

Compare EJH & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EJH
  • KZIA
  • Stock Information
  • Founded
  • EJH 2018
  • KZIA 1994
  • Country
  • EJH China
  • KZIA Australia
  • Employees
  • EJH N/A
  • KZIA N/A
  • Industry
  • EJH Other Consumer Services
  • KZIA Biotechnology: Pharmaceutical Preparations
  • Sector
  • EJH Consumer Discretionary
  • KZIA Health Care
  • Exchange
  • EJH Nasdaq
  • KZIA Nasdaq
  • Market Cap
  • EJH 4.8M
  • KZIA 7.8M
  • IPO Year
  • EJH 2021
  • KZIA 1999
  • Fundamental
  • Price
  • EJH $0.64
  • KZIA $1.08
  • Analyst Decision
  • EJH
  • KZIA Strong Buy
  • Analyst Count
  • EJH 0
  • KZIA 2
  • Target Price
  • EJH N/A
  • KZIA $11.50
  • AVG Volume (30 Days)
  • EJH 1.5M
  • KZIA 5.5M
  • Earning Date
  • EJH 10-29-2024
  • KZIA 03-26-2025
  • Dividend Yield
  • EJH N/A
  • KZIA N/A
  • EPS Growth
  • EJH N/A
  • KZIA N/A
  • EPS
  • EJH N/A
  • KZIA N/A
  • Revenue
  • EJH $50,685,314.00
  • KZIA $1,655,324.00
  • Revenue This Year
  • EJH N/A
  • KZIA $806.89
  • Revenue Next Year
  • EJH N/A
  • KZIA N/A
  • P/E Ratio
  • EJH N/A
  • KZIA N/A
  • Revenue Growth
  • EJH N/A
  • KZIA 248000.00
  • 52 Week Low
  • EJH $0.53
  • KZIA $1.15
  • 52 Week High
  • EJH $36.70
  • KZIA $15.80
  • Technical
  • Relative Strength Index (RSI)
  • EJH 45.78
  • KZIA 32.04
  • Support Level
  • EJH $0.53
  • KZIA $1.31
  • Resistance Level
  • EJH $1.03
  • KZIA $1.60
  • Average True Range (ATR)
  • EJH 0.13
  • KZIA 0.26
  • MACD
  • EJH -0.01
  • KZIA 0.05
  • Stochastic Oscillator
  • EJH 22.24
  • KZIA 0.64

About EJH E-Home Household Service Holdings Limited

E-Home Household Service Holdings Ltd is a household service company providing integrated household services through its website and WeChat platform across China. The company offers services including home appliance and housekeeping services. It operates its business mainly by receiving the orders online and providing the services offline. Its operations are organized into five reportable segments: installation and maintenance services, housekeeping services, senior care services, sales of pharmaceutical products and educational consulting services. The group's principal source of revenue comes from the Installation and Maintenance segment, followed by Housekeeping and Senior care services segment.

About KZIA Kazia Therapeutics Limited

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.

Share on Social Networks: